MULTIPLE MYELOMA IN RELAPSE
Clinical trials for MULTIPLE MYELOMA IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA IN RELAPSE trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to boost Cancer-Fighting CAR-T cells in tough myeloma cases
Disease control Not yet recruitingThis early-stage study is testing whether adding an experimental drug called NT-I7 to standard CAR-T cell therapy helps control multiple myeloma for longer. The research will involve 40 adults with myeloma that has returned or stopped responding to other treatments. Participants …
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Cancer patients test giving their own treatment at home
Disease control Not yet recruitingThis study is testing whether patients with relapsed multiple myeloma can safely and effectively give themselves a standard cancer treatment (daratumumab) at home. Fifty patients will be trained to self-administer the injection, alternating between receiving it at the clinic and …
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE4 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New 'Living Drug' trial offers hope for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis early-stage trial is testing a new personalized cell therapy called S103 for adults with multiple myeloma that has come back or stopped responding to standard treatments. Doctors will collect a patient's own immune cells, modify them to target the cancer, and infuse them bac…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1, PHASE2 • Sponsor: Hebei Senlang Biotechnology Inc., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Turmeric in a shot? early test for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis is a very early study to find the safest dose of a new IV drug made from curcumin, the active part of turmeric. It will involve 20 adults with advanced multiple myeloma that has returned or stopped responding to all standard treatments. The main goal is to see what side effe…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Faster Cancer-Fighting cells tested in groundbreaking trial
Disease control Not yet recruitingThis is a first-in-human study to test the safety of a new, experimental CAR-T cell therapy called UF-KURE-BCMA for patients with multiple myeloma that has returned or stopped responding to standard treatments. The therapy uses a patient's own immune cells, modified in a lab to t…
Matched conditions: MULTIPLE MYELOMA IN RELAPSE
Phase: PHASE1 • Sponsor: David Wald • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC